Literature DB >> 17761822

The ethics of implantable devices.

Eugene B Wu1.   

Abstract

Mesh:

Year:  2007        PMID: 17761822      PMCID: PMC2598199          DOI: 10.1136/jme.2006.019000

Source DB:  PubMed          Journal:  J Med Ethics        ISSN: 0306-6800            Impact factor:   2.903


× No keyword cloud information.
  2 in total

1.  The ethical and legal implications of deactivating an implantable cardioverter-defibrillator in a patient with terminal cancer.

Authors:  Ruth England; Tim England; John Coggon
Journal:  J Med Ethics       Date:  2007-09       Impact factor: 2.903

2.  Views of patients with heart failure about their role in the decision to start implantable cardioverter defibrillator treatment: prescription rather than participation.

Authors:  Anders Agård; Rurik Löfmark; Nils Edvardsson; Inger Ekman
Journal:  J Med Ethics       Date:  2007-09       Impact factor: 2.903

  2 in total
  5 in total

Review 1.  Ethical challenges of deactivation of cardiac devices in advanced heart failure.

Authors:  Hassan Chamsi-Pasha; Mohammed A Chamsi-Pasha; Mohammed Ali Albar
Journal:  Curr Heart Fail Rep       Date:  2014-06

2.  [Dying with/despite a pacemaker].

Authors:  S Reith; U Janssens
Journal:  Med Klin Intensivmed Notfmed       Date:  2014-01-04       Impact factor: 0.840

3.  Ethical Dilemmas and End-of-Life Choices for Patients with Implantable Cardiac Devices: Decisions Regarding Discontinuation of Therapy.

Authors:  Blair P Grubb; Beverly Karabin
Journal:  Curr Treat Options Cardiovasc Med       Date:  2011-10

Review 4.  [Ethics in intensive care and euthanasia : With respect to inactivating defibrillators at the end of life in terminally ill patients].

Authors:  H-J Trappe
Journal:  Med Klin Intensivmed Notfmed       Date:  2015-11-17       Impact factor: 0.840

Review 5.  The deactivation of implantable cardioverter-defibrillators: medical, ethical, practical, and legal considerations.

Authors:  Jörg Carlsson; Norbert W Paul; Matthias Dann; Jörg Neuzner; Dietrich Pfeiffer
Journal:  Dtsch Arztebl Int       Date:  2012-08-20       Impact factor: 5.594

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.